23andMe Holding Co.

NASDAQ: ME · Real-Time Price · USD
0.61
0.00 (0.61%)
At close: Mar 28, 2025, 3:59 PM

23andMe Income Statement

Financials in USD. Fiscal year is April - March.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Mar 31, 2025 Mar 31, 2024 Mar 31, 2023 Mar 31, 2022
Revenue
189.9M 219.64M 299.49M 271.89M
Cost of Revenue
89.89M 120.26M 164.99M 138.95M
Gross Profit
100M 99.38M 134.5M 132.94M
Operating Income
-240.64M -321.36M -324.01M -254.15M
Interest Income
6.6M 14.33M 9.68M 277K
Pretax Income
-235.24M -666.63M -314.43M -220.97M
Net Income
-280.88M -666.7M -311.66M -217.49M
Selling & General & Admin
172.31M 205.74M 235.91M 197.72M
Research & Development
101.59M 205.36M 222.6M 189.38M
Other Expenses
66.75M 9.63M -93K -83K
Operating Expenses
340.64M 420.73M 458.51M 387.1M
Interest Expense
n/a n/a n/a n/a
Selling & Marketing Expenses
39.99M 85.6M 119.93M 100.34M
Cost & Expenses
430.54M 540.99M 623.5M 526.05M
Income Tax Expense
-41K 73K -2.77M -3.48M
Shares Outstanding (Basic)
25.82M 24.17M 22.58M 21.83M
Shares Outstanding (Diluted)
25.82M 23.8M 22.58M 21.83M
EPS (Basic)
-10.88 -27.59 -13.81 -9.96
EPS (Diluted)
-10.88 -28.01 -13.81 -9.96
EBITDA
-155.85M -291.87M -291.94M -228M
EBIT
-179.2M -321.36M -324.01M -254.15M
Depreciation & Amortization
23.35M 29.48M 36.5M 26.15M